Fagron NV | Large-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2019

Income Metrics

EPS (Diluted) €0.00

Balance Sheet Metrics

Total Assets 1.1B
Total Liabilities 578.2M
Shareholders Equity 505.4M
Debt to Equity 1.14

Cash Flow Metrics

Revenue & Profitability Trend

Fagron NV Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i872.0M763.0M683.9M573.8M556.0M
Cost of Goods Sold i476.3M430.4M397.7M326.3M309.2M
Gross Profit i395.7M332.6M286.2M247.5M246.7M
Gross Margin % i45.4%43.6%41.8%43.1%44.4%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-----
Other Operating Expenses i4.2M2.3M6.1M2.3M2.8M
Total Operating Expenses i4.2M2.3M6.1M2.3M2.8M
Operating Income i134.4M112.7M101.2M89.9M92.4M
Operating Margin % i15.4%14.8%14.8%15.7%16.6%
Non-Operating Items
Interest Income i4.4M5.3M4.1M1.4M753.0K
Interest Expense i17.4M15.2M10.6M8.0M10.9M
Other Non-Operating Income-----
Pre-tax Income i104.3M84.4M87.8M76.8M73.7M
Income Tax i23.3M13.4M17.7M15.4M13.7M
Effective Tax Rate % i22.3%15.9%20.2%20.1%18.6%
Net Income i81.0M71.0M70.1M61.4M60.0M
Net Margin % i9.3%9.3%10.2%10.7%10.8%
Key Metrics
EBITDA i164.0M141.9M128.2M112.4M115.9M
EPS (Basic) i€1.10€0.97€0.96€0.84€0.83
EPS (Diluted) i€1.10€0.97€0.96€0.84€0.82
Basic Shares Outstanding i7293700073000000728750007264300072089385
Diluted Shares Outstanding i7293700073000000728750007264300072089385

Income Statement Trend

Fagron NV Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i115.0M133.0M125.3M70.6M84.2M
Short-term Investments i886.0K4.3M451.0K--
Accounts Receivable i82.0M62.1M60.7M51.9M42.1M
Inventory i137.0M113.9M108.3M90.8M79.8M
Other Current Assets27.7M22.6M23.2M-2.0K-1.0K
Total Current Assets i362.6M335.9M318.0M233.7M221.9M
Non-Current Assets
Property, Plant & Equipment i193.1M172.7M165.6M136.6M113.6M
Goodwill i955.3M917.3M893.2M791.5M753.8M
Intangible Assets i61.4M48.6M33.6M30.7M24.5M
Long-term Investments553.0K2.5M13.3M1.2M-
Other Non-Current Assets-----
Total Non-Current Assets i721.0M671.1M653.0M566.7M530.9M
Total Assets i1.1B1.0B971.0M800.4M752.8M
Liabilities
Current Liabilities
Accounts Payable i114.3M104.9M97.9M83.7M72.3M
Short-term Debt i9.5M9.7M19.0M14.3M71.1M
Current Portion of Long-term Debt-----
Other Current Liabilities-1.0K-2.0K1.0K4.2M
Total Current Liabilities i194.7M175.3M171.0M145.1M200.3M
Non-Current Liabilities
Long-term Debt i376.2M357.1M380.4M321.3M284.4M
Deferred Tax Liabilities i1.8M2.0M4.4M2.5M2.1M
Other Non-Current Liabilities---1.0K1.0K-
Total Non-Current Liabilities i383.4M364.1M389.5M329.9M294.8M
Total Liabilities i578.2M539.3M560.5M475.0M495.0M
Equity
Common Stock i524.5M524.5M521.2M520.8M514.0M
Retained Earnings i264.9M206.3M150.3M95.3M47.3M
Treasury Stock i23.9M21.1M18.8M18.8M18.8M
Other Equity-----
Total Shareholders Equity i505.4M467.6M410.5M325.5M257.8M
Key Metrics
Total Debt i385.7M366.7M399.4M335.6M355.5M
Working Capital i167.9M160.6M147.0M88.6M21.6M

Balance Sheet Composition

Fagron NV Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i104.3M84.4M87.8M76.8M73.7M
Depreciation & Amortization i-----
Stock-Based Compensation i1.2M2.4M1.8M3.3M1.5M
Working Capital Changes i-34.8M-6.3M-2.1M-22.7M-10.2M
Operating Cash Flow i97.1M104.8M92.1M68.0M80.0M
Investing Activities
Capital Expenditures i-26.2M-20.3M---
Acquisitions i-28.9M-6.3M-50.8M-11.2M-32.9M
Investment Purchases i-----
Investment Sales i----0
Investing Cash Flow i-55.2M-26.6M-50.8M-11.2M-32.9M
Financing Activities
Share Repurchases i-2.9M-2.3M0--
Dividends Paid i-21.0M-18.3M-14.6M-13.0M-5.8M
Debt Issuance i52.5M0135.0M66.2M63.6M
Debt Repayment i-44.0M-28.0M-85.7M-99.5M-92.5M
Financing Cash Flow i-11.1M-39.9M38.7M-38.0M-30.0M
Free Cash Flow i69.1M86.2M91.0M57.7M74.5M
Net Change in Cash i30.9M38.2M80.1M18.9M17.1M

Cash Flow Trend

Fagron NV Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 17.65
Forward P/E 15.64
Price to Book 3.01
Price to Sales 1.67
PEG Ratio 15.64

Profitability Ratios

Profit Margin 9.33%
Operating Margin 15.38%
Return on Equity 17.53%
Return on Assets 8.06%

Financial Health

Current Ratio 1.76
Debt to Equity 80.02
Beta 0.25

Per Share Data

EPS (TTM) €1.17
Book Value per Share €6.86
Revenue per Share €12.60

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
fagr1.5B17.653.0117.53%9.33%80.02
Argenx SE 36.2B33.975.7824.72%41.03%0.71
UCB S.A 35.1B26.923.6214.30%19.45%29.72
Ion Beam 350.0M38.583.168.52%1.86%39.39
Nyxoah S.A 246.8M-3.592.62-77.44%65.67%23.79
Hyloris 187.6M-5.84-17.81%-64.98%5.65

Financial data is updated regularly. All figures are in the company's reporting currency.